Advertisement
Screener

BEONE MEDICINES LTD. (ONC) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

2.8 / 5 stars · 68/120 Roast Me

BEONE MEDICINES LTD. Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

BEONE MEDICINES LTD. (ONC) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax of -$32.16 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.

Discontinued › Income Statement › Unrealized Gains

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax · last filed 2024-05-08

  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2024-03-31 was -$32.16M, a 340.98% decline year-over-year.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2023-03-31 was $13.35M.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2021-12-31 was $7.19M, a 55.30% decline year-over-year.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for the quarter ending 2021-09-30 was $664.00K, a 93.45% decline year-over-year.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2023 was -$25.46M.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2022 was -$90.42M, a 759.33% decline from fiscal 2021.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2021 was $13.71M, a 41.90% decline from fiscal 2020.
  • BEONE MEDICINES LTD. other comprehensive income (loss), foreign currency transaction and translation adjustment, net of tax for fiscal 2020 was $23.60M.
Period endOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 3 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 6 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 9 monthOther Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 12 month
2024-03-31-$32.16M
10-Q · filed 2024-05-08
2023-12-31-$25.46M
10-K · filed 2024-02-26
2023-03-31$13.35M
10-Q · filed 2024-05-08
2022-12-31-$90.42M
10-K · filed 2024-02-26
2021-12-31$7.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$7.85M
derived: sum of 2 quarters · filed 2024-02-26
$17.48M
derived: sum of 3 quarters · filed 2024-02-26
$13.71M
10-K · filed 2024-02-26
2021-09-30$664.00K
10-Q · filed 2021-11-04
$10.29M
derived: sum of 2 quarters · filed 2021-11-04
$6.53M
10-Q · filed 2021-11-04
$22.61M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$9.63M
10-Q · filed 2021-08-05
$5.86M
10-Q · filed 2021-08-05
$21.94M
derived: sum of 3 quarters · filed 2023-02-27
$32.08M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31-$3.76M
10-Q · filed 2021-05-06
$12.31M
derived: sum of 2 quarters · filed 2023-02-27
$22.46M
derived: sum of 3 quarters · filed 2023-02-27
$24.19M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$16.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$26.22M
derived: sum of 2 quarters · filed 2023-02-27
$27.95M
derived: sum of 3 quarters · filed 2023-02-27
$23.60M
10-K · filed 2023-02-27
2020-09-30$10.14M
10-Q · filed 2021-11-04
$11.88M
derived: sum of 2 quarters · filed 2021-11-04
$7.53M
10-Q · filed 2021-11-04
$15.35M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$1.73M
10-Q · filed 2021-08-05
-$2.62M
10-Q · filed 2021-08-05
$5.21M
derived: sum of 3 quarters · filed 2022-02-28
-$8.46M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$4.35M
10-Q · filed 2021-05-06
$3.48M
derived: sum of 2 quarters · filed 2022-02-28
-$10.19M
derived: sum of 3 quarters · filed 2022-02-28
-$17.53M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$7.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
-$5.84M
derived: sum of 2 quarters · filed 2022-02-28
-$13.18M
derived: sum of 3 quarters · filed 2022-02-28
-$9.42M
10-K · filed 2022-02-28
2019-09-30-$13.67M
10-Q · filed 2020-11-05
-$21.01M
derived: sum of 2 quarters · filed 2020-11-05
-$17.25M
10-Q · filed 2020-11-05
-$15.82M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$7.34M
10-Q · filed 2020-08-06
-$3.58M
10-Q · filed 2020-08-06
-$2.15M
derived: sum of 3 quarters · filed 2021-02-25
-$6.37M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$3.75M
10-Q · filed 2020-05-11
$5.19M
derived: sum of 2 quarters · filed 2021-02-25
$972.00K
derived: sum of 3 quarters · filed 2021-02-25
$3.00M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$1.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
-$2.78M
derived: sum of 2 quarters · filed 2021-02-25
-$750.00K
derived: sum of 3 quarters · filed 2021-02-25
-$478.00K
10-K · filed 2021-02-25
2018-09-30-$4.22M
10-Q · filed 2019-11-12
-$2.18M
derived: sum of 2 quarters · filed 2019-11-12
-$1.91M
10-Q · filed 2019-11-12
-$2.05M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$2.03M
10-Q · filed 2019-08-08
$2.31M
10-Q · filed 2019-08-08
$2.17M
derived: sum of 3 quarters · filed 2020-03-02
$2.51M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$272.00K
10-Q · filed 2019-05-09
$138.00K
derived: sum of 2 quarters · filed 2020-03-02
$479.00K
derived: sum of 3 quarters · filed 2020-03-02
$1.03M
derived: sum of 4 quarters · filed 2020-03-02
2017-12-31-$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$207.00K
derived: sum of 2 quarters · filed 2020-03-02
$761.00K
derived: sum of 3 quarters · filed 2020-03-02
$851.00K
10-K · filed 2020-03-02
2017-09-30$341.00K
10-Q · filed 2018-11-08
$895.00K
derived: sum of 2 quarters · filed 2018-11-08
$985.00K
10-Q · filed 2018-11-08
$753.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$554.00K
10-Q · filed 2018-08-09
$644.00K
10-Q · filed 2018-08-09
$412.00K
derived: sum of 3 quarters · filed 2019-02-28
$789.00K
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$90.00K
10-Q · filed 2018-05-09
-$142.00K
derived: sum of 2 quarters · filed 2019-02-28
$235.00K
derived: sum of 3 quarters · filed 2019-02-28
-$251.00K
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$232.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$145.00K
derived: sum of 2 quarters · filed 2019-02-28
-$341.00K
derived: sum of 3 quarters · filed 2019-02-28
-$245.00K
10-K · filed 2019-02-28
2016-09-30$377.00K
10-Q · filed 2017-11-13
-$109.00K
derived: sum of 2 quarters · filed 2017-11-13
-$13.00K
10-Q · filed 2017-11-13
-$252.00K
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30-$486.00K
10-Q · filed 2017-08-09
-$390.00K
10-Q · filed 2017-08-09
-$629.00K
derived: sum of 3 quarters · filed 2018-02-28
-$1.06M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$97.00K
10-Q · filed 2017-05-10
-$143.00K
derived: sum of 2 quarters · filed 2018-02-28
-$571.00K
derived: sum of 3 quarters · filed 2018-02-28
-$603.00K
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31-$240.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
-$668.00K
derived: sum of 2 quarters · filed 2018-02-28
-$700.00K
derived: sum of 3 quarters · filed 2018-02-28
-$749.00K
10-K · filed 2018-02-28
2015-09-30-$428.00K
10-Q · filed 2016-11-10
-$460.00K
derived: sum of 2 quarters · filed 2016-11-10
-$509.00K
10-Q · filed 2016-11-10
2015-06-30-$32.00K
10-Q · filed 2016-08-10
-$81.00K
10-Q · filed 2016-08-10
2015-03-31-$50.00K
10-Q · filed 2016-05-12
2014-12-31-$168.00K
10-K · filed 2017-03-22